Sergey Shevkoplyas
Office Location: SERC 2009
Phone: 713-743-5696
Fax: 713-743-0226
Email: sshevkop [at] central.uh.edu

Dr. Shevkoplyas is an Associate Professor in the Department of Biomedical Engineering at the University of Houston.  He received his B.S. and M.S. degrees in Applied Mathematics & Physics from Moscow Institute of Physics & Technology, Russia in 2000, and his Ph.D. degree in Biomedical Engineering from Boston University in 2005.  Dr. Shevkoplyas also completed a postdoctoral fellowship in Chemistry and Chemical Biology at Harvard University (2005 – 2008), and served on the faculty of Tulane University as an Assistant and Associate Professor of Biomedical Engineering (2008 – 2013).

Dr. Shevkoplyas is a biomedical engineer with core expertise in blood microfluidics.  He has authored more than 40 peer-reviewed articles, published several book chapters and is an inventor on more than 14 U.S. patents and patent applications.  His research has been funded by the National Blood Foundation, the Bill & Melinda Gates Foundation, U.S. Army and the National Institutes of Health, including the 2012 NIH Director's Transformative Research Award (T-R01).


Biomedical Processes (BIOE 2331)

Awards and Honors: 

2014: Adjunct Associate Professor, Department of Pediatrics, Baylor College of Medicine, Houston, TX
2011 – 2013: Newcomb Fellow, Newcomb College Institute of Tulane University, New Orleans, LA
2008 – 2013: The Ken and Ruth Arnold Early Career Professor in Biomedical Engineering, Tulane University, New Orleans, LA
2004: BMES Poster Award for “Outstanding Scientific & Engineering Innovation”
2003 – 2005: American Heart Association (AHA) Predoctoral Fellowship Award

Research Interests: 

The primary focus of the Blood Microfluidics Laboratory is the development and clinical translation of high-throughput microfluidic devices and single-cell analysis tools in the field of blood storage and transfusion medicine.  We are currently developing novel technologies for improving the safety and efficacy of blood transfusions, and making blood products available for life-saving transfusions in resource-limited settings.  An additional significant thrust of our research program is the development of enabling technology for low-cost, point-of-care diagnostics in resource-limited settings.